Fundraising FoxTransMedics
NASDAQ: TMDXAndover, US · Delaware corporation · 2 known investors
Find your way into TransMedics
Sign up to see every warm intro you have to TransMedics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the TransMedics team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
TransMedics develops and sells the Organ Care System (OCS), a portable warm perfusion platform for preserving and assessing donor hearts, lungs, and livers outside the body prior to transplantation, along with the National OCS Program, an end-to-end organ procurement and logistics service for transplant centers that includes aircraft and ground transportation. The company serves transplant centers, hospitals, and patients requiring organ transplants.
Founders & leadership
Board
Investors · 2
How we know: Alta Partners's portfolio page · Not right? Tell us
How we know: the S-1 prospectus · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$84.2M disclosed across 3 of 7 rounds · 1900–2016
▶$63.7MraisedJul 2016 · 20 investors · Other Health CareRule 506(b)
- Edward BasileDirector
- Travis RhodesDirector
- Waleed H. HassaneinExecutive Officer, Director
- Stephen GordonExecutive Officer
- James R. TobinDirector
- James GilbertDirector
- Dmitry KobyzevDirector
- Edwin M. Kania, Jr.Director
- David AbramsDirector
- Offering amount
- $63.7M
- Amount sold
- $63.7M
- First sale
- May 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$500KraisedSep 2015 · 1 investors · Other Health CareRule 506(b)
- Joseph S. LacobDirector
- David AbramsDirector
- Stephen GordonExecutive Officer
- Waleed H. HassaneinExecutive Officer, Director
- Travis RhodesDirector
- Earl M. Collier, Jr.Director
- Tony Lee WhiteDirector
- Kenneth BateDirector
- Edwin M. Kania, Jr.Director
- James R. TobinDirector
- Offering amount
- $500K
- Amount sold
- $500K
- First sale
- Sep 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$20MraisedJun 2015 · 11 investors · Other Health CareRule 506(b)
- Edwin M. Kania, Jr.Director
- Waleed H. HassaneinExecutive Officer, Director
- James R. TobinDirector
- Kenneth BateDirector
- David AbramsDirector
- Joseph S. LacobDirector
- Earl M. Collier, Jr.Director
- Travis RhodesDirector
- Tony Lee WhiteDirector
- Stephen GordonExecutive Officer
- Offering amount
- $20M
- Amount sold
- $20M
- First sale
- May 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed eventsSource: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Frequently asked questions
- What does TransMedics do?
- TransMedics develops and sells the Organ Care System (OCS), a portable warm perfusion platform for preserving and assessing donor hearts, lungs, and livers outside the body prior to transplantation, along with the National OCS Program, an end-to-end organ procurement and logistics service for transplant centers that includes aircraft and ground transportation. The company serves transplant centers, hospitals, and patients requiring organ transplants.
- Who founded TransMedics?
- TransMedics was founded by Waleed H. Hassanein.
- Who are TransMedics's investors?
- TransMedics's investors include Alta Partners, Flagship Pioneering.
- How much funding has TransMedics raised?
- TransMedics has disclosed $84.2M raised across 3 of its 7 known rounds.
- Where is TransMedics headquartered?
- TransMedics is headquartered in Andover, US.